Figures computed from official regulatory filings — .
Analysttarget 15.09 USD (+101%) · consensus 4.67/5 · 11 buy · 1 hold · 0 sell
Ownershipinsiders 12.5% · institutions 91.21% · short 25.2% of float · 8.65d to cover
In USD · as of Nov 16, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Absci Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Market information source · Nov 16, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Nov 16, 2026
Purchases and sales · full history
20 buys10 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| McClain Sean | Other | $966.3K | Unusual size | SEC | |
| Bedrick Todd | Other | $226.8K | Unusual size | SEC | |
| McClain Sean | Other | $236.7K | SEC | ||
| Jonasson Zachariah | Other | $3.9K | SEC | ||
| Jonasson Zachariah | Other | $72.5K | SEC | ||
| Somaratne Ransi Mudalinayake | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Somaratne Ransi Mudalinayake | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Szela Mary Ttrack record | Buy | $148.9K | conv 66Unusual size | SEC | |
| McClain Sean | Other | $603.5K | SEC | ||
| Szela Mary Ttrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Szela Mary Ttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Sirosh Joseph | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Pangalos Menelas N | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Szela Mary Ttrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Rabinovitsj Daniel A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Rabinovitsj Daniel A | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| VAN HOUTEN FRANS | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Szela Mary Ttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Sirosh Joseph | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| VAN HOUTEN FRANS | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Pangalos Menelas N | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Jonasson Zachariah | Other | $56.2K | SEC | ||
| Pangalos Menelas N | Buy | $200.7K | conv 38 | SEC | |
| Walker Shelby J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Bedrick Todd | Other | $14.8K | SEC |